Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 9.69%3.12B | 4.90%824.31M | 10.30%798.92M | 11.41%784.79M | 13.05%713.17M | 11.28%2.85B | 3.71%785.79M | 14.87%724.33M | 15.60%704.4M | 12.76%630.86M |
Operating revenue | 9.69%3.12B | 4.90%824.31M | 10.30%798.92M | 11.41%784.79M | 13.05%713.17M | 11.28%2.85B | 3.71%785.79M | 14.87%724.33M | 15.60%704.4M | 12.76%630.86M |
Cost of revenue | 10.65%1.97B | 5.37%506.88M | 13.05%500.66M | 12.56%500.69M | 12.20%459.41M | 10.97%1.78B | 3.41%481.06M | 11.18%442.86M | 16.80%444.82M | 14.35%409.45M |
Gross profit | 8.09%1.15B | 4.17%317.43M | 5.97%298.26M | 9.45%284.1M | 14.61%253.76M | 11.79%1.07B | 4.19%304.73M | 21.21%281.47M | 13.59%259.57M | 9.93%221.41M |
Operating expense | 4.79%610.5M | 7.16%154.34M | 0.76%150.08M | 3.74%152.29M | 7.70%153.79M | 10.65%582.58M | 6.50%144.04M | 19.52%148.95M | 12.57%146.8M | 4.81%142.79M |
Selling and administrative expenses | 4.44%518.86M | 3.70%128.56M | 3.08%129.35M | 2.80%130.13M | 8.32%130.81M | 11.47%496.81M | 6.68%123.97M | 17.01%125.49M | 18.82%126.59M | 4.39%120.77M |
-Selling and marketing expense | 6.03%145.36M | -0.41%36.16M | 9.47%37.31M | 2.49%35.13M | 13.38%36.77M | 12.75%137.09M | 16.37%36.31M | 6.89%34.08M | 12.71%34.27M | 15.42%32.43M |
-General and administrative expense | 3.83%373.5M | 5.41%92.41M | 0.69%92.04M | 2.92%95.01M | 6.46%94.05M | 10.99%359.72M | 3.12%87.66M | 21.30%91.4M | 21.25%92.32M | 0.85%88.34M |
Research and development costs | 6.86%91.65M | 28.48%25.78M | -11.63%20.73M | 9.61%22.15M | 4.34%22.98M | 6.10%85.76M | 5.43%20.07M | 34.95%23.46M | -15.33%20.21M | 7.18%22.02M |
Operating profit | 12.06%543.05M | 1.49%163.09M | 11.82%148.18M | 16.88%131.82M | 27.15%99.96M | 13.20%484.6M | 2.19%160.69M | 23.18%132.52M | 14.95%112.78M | 20.65%78.62M |
Net non-operating interest income expense | 12.69%-44.87M | -6.51%-11.68M | 8.71%-11.41M | 25.19%-11.22M | 18.34%-10.57M | -9.39%-51.39M | 19.79%-10.96M | 10.72%-12.5M | -53.17%-14.99M | -35.82%-12.94M |
Non-operating interest expense | -12.69%44.87M | 6.51%11.68M | -8.71%11.41M | -25.19%11.22M | -18.34%10.57M | 9.39%51.39M | -19.79%10.96M | -10.72%12.5M | 53.17%14.99M | 35.82%12.94M |
Other net income (expense) | -20.03%23.88M | -74.93%1.78M | -2.52%6.85M | -29.07%5.64M | 23.70%9.61M | 269.52%29.86M | 396.30%7.12M | 87.48%7.02M | 74.62%7.95M | 569.59%7.77M |
Special income (charges) | ---14.45M | ---8.25M | ---3.28M | ---2.92M | ---- | --0 | --0 | --0 | --0 | ---- |
-Less:Restructuring and merger&acquisition | --14.45M | --8.25M | --3.28M | --2.92M | ---- | --0 | --0 | --0 | --0 | ---- |
-Gain on sale of business | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 28.35%38.33M | 40.99%10.03M | 44.18%10.13M | 7.62%8.56M | 23.70%9.61M | 134.54%29.86M | 396.30%7.12M | 87.48%7.02M | 74.62%7.95M | 159.16%7.77M |
Income before tax | 12.74%522.06M | -2.33%153.2M | 13.05%143.62M | 19.39%126.24M | 34.81%99M | 18.98%463.07M | 8.16%156.85M | 30.53%127.05M | 13.85%105.74M | 36.05%73.44M |
Income tax | 7.85%117.08M | -4.38%35.34M | 7.25%32.46M | 8.21%26.77M | 35.63%22.5M | 14.46%108.56M | 2.70%36.96M | 28.45%30.27M | 12.45%24.74M | 24.83%16.59M |
Net income | 14.24%404.98M | -1.70%117.85M | 14.86%111.16M | 22.81%99.47M | 34.57%76.5M | 20.44%354.51M | 9.96%119.89M | 31.19%96.78M | 14.29%81M | 39.72%56.85M |
Net income continuous Operations | 14.24%404.98M | -1.70%117.85M | 14.86%111.16M | 22.81%99.47M | 34.57%76.5M | 20.44%354.51M | 9.96%119.89M | 31.19%96.78M | 14.29%81M | 39.72%56.85M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 14.24%404.98M | -1.70%117.85M | 14.86%111.16M | 22.81%99.47M | 34.57%76.5M | 20.44%354.51M | 9.96%119.89M | 31.19%96.78M | 14.29%81M | 39.72%56.85M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 14.24%404.98M | -1.70%117.85M | 14.86%111.16M | 22.81%99.47M | 34.57%76.5M | 20.44%354.51M | 9.96%119.89M | 31.19%96.78M | 14.29%81M | 39.72%56.85M |
Basic earnings per share | 14.58%10.61 | -0.96%3.11 | 15.02%2.91 | 23.22%2.6 | 35.14%2 | 20.73%9.26 | 10.18%3.14 | 31.77%2.53 | 14.67%2.11 | 39.62%1.48 |
Diluted earnings per share | 14.67%10.55 | -0.64%3.09 | 15.14%2.89 | 22.86%2.58 | 34.46%1.99 | 20.73%9.2 | 10.28%3.11 | 31.41%2.51 | 14.75%2.1 | 40.95%1.48 |
Dividend per share | 5.06%0.83 | 5.00%0.21 | 5.00%0.21 | 5.00%0.21 | 5.26%0.2 | 5.33%0.79 | 5.26%0.2 | 5.26%0.2 | 5.26%0.2 | 5.56%0.19 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |